DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues

Abstract Homeodomains (HDs) are the second largest class of DNA binding domains (DBDs) among eukaryotic sequence-specific transcription factors (TFs) and are the TF structural class with the largest number of disease-associated mutations in the Human Gene Mutation Database (HGMD). Despite numerous s...

Full description

Bibliographic Details
Main Authors: Kian Hong Kock, Patrick K. Kimes, Stephen S. Gisselbrecht, Sachi Inukai, Sabrina K. Phanor, James T. Anderson, Gayatri Ramakrishnan, Colin H. Lipper, Dongyuan Song, Jesse V. Kurland, Julia M. Rogers, Raehoon Jeong, Stephen C. Blacklow, Rafael A. Irizarry, Martha L. Bulyk
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-47396-0
_version_ 1797209249879687168
author Kian Hong Kock
Patrick K. Kimes
Stephen S. Gisselbrecht
Sachi Inukai
Sabrina K. Phanor
James T. Anderson
Gayatri Ramakrishnan
Colin H. Lipper
Dongyuan Song
Jesse V. Kurland
Julia M. Rogers
Raehoon Jeong
Stephen C. Blacklow
Rafael A. Irizarry
Martha L. Bulyk
author_facet Kian Hong Kock
Patrick K. Kimes
Stephen S. Gisselbrecht
Sachi Inukai
Sabrina K. Phanor
James T. Anderson
Gayatri Ramakrishnan
Colin H. Lipper
Dongyuan Song
Jesse V. Kurland
Julia M. Rogers
Raehoon Jeong
Stephen C. Blacklow
Rafael A. Irizarry
Martha L. Bulyk
author_sort Kian Hong Kock
collection DOAJ
description Abstract Homeodomains (HDs) are the second largest class of DNA binding domains (DBDs) among eukaryotic sequence-specific transcription factors (TFs) and are the TF structural class with the largest number of disease-associated mutations in the Human Gene Mutation Database (HGMD). Despite numerous structural studies and large-scale analyses of HD DNA binding specificity, HD-DNA recognition is still not fully understood. Here, we analyze 92 human HD mutants, including disease-associated variants and variants of uncertain significance (VUS), for their effects on DNA binding activity. Many of the variants alter DNA binding affinity and/or specificity. Detailed biochemical analysis and structural modeling identifies 14 previously unknown specificity-determining positions, 5 of which do not contact DNA. The same missense substitution at analogous positions within different HDs often exhibits different effects on DNA binding activity. Variant effect prediction tools perform moderately well in distinguishing variants with altered DNA binding affinity, but poorly in identifying those with altered binding specificity. Our results highlight the need for biochemical assays of TF coding variants and prioritize dozens of variants for further investigations into their pathogenicity and the development of clinical diagnostics and precision therapies.
first_indexed 2024-04-24T09:51:42Z
format Article
id doaj.art-fb03d33422b540199802faeaf082a440
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-24T09:51:42Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-fb03d33422b540199802faeaf082a4402024-04-14T11:21:34ZengNature PortfolioNature Communications2041-17232024-04-0115111910.1038/s41467-024-47396-0DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residuesKian Hong Kock0Patrick K. Kimes1Stephen S. Gisselbrecht2Sachi Inukai3Sabrina K. Phanor4James T. Anderson5Gayatri Ramakrishnan6Colin H. Lipper7Dongyuan Song8Jesse V. Kurland9Julia M. Rogers10Raehoon Jeong11Stephen C. Blacklow12Rafael A. Irizarry13Martha L. Bulyk14Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer InstituteDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical SchoolDepartment of Biostatistics, Harvard T.H. Chan School of Public HealthDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolProgram in Biological and Biomedical Sciences, Harvard UniversityDepartment of Data Science, Dana-Farber Cancer InstituteDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical SchoolAbstract Homeodomains (HDs) are the second largest class of DNA binding domains (DBDs) among eukaryotic sequence-specific transcription factors (TFs) and are the TF structural class with the largest number of disease-associated mutations in the Human Gene Mutation Database (HGMD). Despite numerous structural studies and large-scale analyses of HD DNA binding specificity, HD-DNA recognition is still not fully understood. Here, we analyze 92 human HD mutants, including disease-associated variants and variants of uncertain significance (VUS), for their effects on DNA binding activity. Many of the variants alter DNA binding affinity and/or specificity. Detailed biochemical analysis and structural modeling identifies 14 previously unknown specificity-determining positions, 5 of which do not contact DNA. The same missense substitution at analogous positions within different HDs often exhibits different effects on DNA binding activity. Variant effect prediction tools perform moderately well in distinguishing variants with altered DNA binding affinity, but poorly in identifying those with altered binding specificity. Our results highlight the need for biochemical assays of TF coding variants and prioritize dozens of variants for further investigations into their pathogenicity and the development of clinical diagnostics and precision therapies.https://doi.org/10.1038/s41467-024-47396-0
spellingShingle Kian Hong Kock
Patrick K. Kimes
Stephen S. Gisselbrecht
Sachi Inukai
Sabrina K. Phanor
James T. Anderson
Gayatri Ramakrishnan
Colin H. Lipper
Dongyuan Song
Jesse V. Kurland
Julia M. Rogers
Raehoon Jeong
Stephen C. Blacklow
Rafael A. Irizarry
Martha L. Bulyk
DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues
Nature Communications
title DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues
title_full DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues
title_fullStr DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues
title_full_unstemmed DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues
title_short DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues
title_sort dna binding analysis of rare variants in homeodomains reveals homeodomain specificity determining residues
url https://doi.org/10.1038/s41467-024-47396-0
work_keys_str_mv AT kianhongkock dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT patrickkkimes dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT stephensgisselbrecht dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT sachiinukai dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT sabrinakphanor dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT jamestanderson dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT gayatriramakrishnan dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT colinhlipper dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT dongyuansong dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT jessevkurland dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT juliamrogers dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT raehoonjeong dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT stephencblacklow dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT rafaelairizarry dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues
AT marthalbulyk dnabindinganalysisofrarevariantsinhomeodomainsrevealshomeodomainspecificitydeterminingresidues